Evidence map›Paper›PMID 28959742›Full record

ArticlemSphere

The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of

Jannik Donner, Michael Reck, Boyke Bunk, Michael Jarek, Constantin Benjamin App, Jan P Meier-Kolthoff, Jörg Overmann, Rolf Müller, Andreas Kirschning, Irene Wagner-Döbler

Abstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Purine metabolism regulatesFrontiers in microbiology · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jannik DonnerDepartment of Medical Microbiology, Group Microbial Communication, Helmholtz-Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0002-1115-8714
Michael ReckDepartment of Medical Microbiology, Group Microbial Communication, Helmholtz-Centre for Infection Research, Braunschweig, Germany.
Boyke BunkLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Michael JarekGenome Analytics, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Constantin Benjamin AppDepartment of Medical Microbiology, Group Microbial Communication, Helmholtz-Centre for Infection Research, Braunschweig, Germany.
Jan P Meier-KolthoffLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Jörg OvermannLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Rolf MüllerDepartment of Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research and Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany.
Andreas KirschningInstitute of Organic Chemistry and Center of Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Hannover, Germany.
Irene Wagner-DöblerDepartment of Medical Microbiology, Group Microbial Communication, Helmholtz-Centre for Infection Research, Braunschweig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The myxobacterial secondary metabolite carolacton inhibits growth of

Indexed as

antimicrobial activityantimicrobial agentscarolactondrug effluxdrug resistance mechanismsefflux pumpsgene sequencinggenome analysisGram-negative bacteria

Identifiers

PMID28959742
PMCPMC5615136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.